lobbying_activities: 2299104
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2299104 | e299954a-a06f-4380-b562-6fc0d84dde8a | 2A | AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY | 46803 | AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY | 2019 | second_quarter | HCR | SENATE - Public Health Funding Restoration Act Worked with Senator Richard Blumenthal (D-CT) on supporting the introduction of the Public Health Restoration Act and signed on as a supporting organization. ADMINISTRATION - Letter to White House, OMB, POTUS and HHS Opposing FDA Guidance Signed onto letter led by Friends of Cancer research to the Administration, Mick Mulvaney, Russel Vought, Trump and Alexander Azar voicing opposition to FDA guidance documents. SENATE - Cannabidiol and Marijuana Research Expansion Act Signed letter led by American Psychological Association addressed to Senate leaders asking for the reintroduction of the Cannabidiol and Marijuana Research Expansion Act. HOUSE - Rep. Buddy Carter Amendment Rec. to H.R. 987 Strengthening Healthcare and Lowering Prescription Drug Cost Act Contacted by Rep. Buddy Carters office regarding amendment to H.R. 987 Strengthening Healthcare and Lower Prescription Drug Cost Act which included provision regarding outreach to colleges of pharmacy by the Secretary of HHS and Education with respect to materials related to generic drugs and biosimilar. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office | 30000 | 0 | 0 | 2019-07-03T10:26:23.597000-04:00 |